Filing Details
- Accession Number:
- 0001213900-22-008683
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-22 16:06:01
- Reporting Period:
- 2022-02-17
- Accepted Time:
- 2022-02-22 16:06:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1779020 | Danimer Scientific Inc. | DNMR | Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821) | 841924518 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1836650 | Eric Michael Smith | C/O Danimer Scientific, Inc. 140 Industrial Boulevard Bainbridge GA 39817 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock ("Common Stock") | Acquisiton | 2022-02-17 | 10,000 | $3.28 | 358,744 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-02-17 | 10,000 | $4.05 | 348,744 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to purchase) | Disposition | 2022-02-17 | 10,000 | $0.00 | 10,000 | $3.28 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
608,909 | 2026-06-30 | No | 4 | M | Direct |
Footnotes
- Includes 348,744 restricted shares of the Common Stock granted under a previously disclosed restricted stock award.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Smith on June 25, 2021. The Reporting Person exercised no discretion with respect to the sale. Proceeds from the sale were used to pay the exercise price of stock options, pursuant to a broker-assisted cashless exercise, and applicable withholding taxes.
- The options are fully vested and currently exercisable.